New
Image
17.03.2026
Study reveals inequity in access to diabetes tech
Science and medical writer, Susan Aldridge PhD, reviews a study on equitable access to continuous glucose...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more